Identification of RPGR ORF15 mutation for X-linked retinitis pigmentosa in a large Chinese family and in vitro correction with prime editor

Xiujuan Lv,Zheng Zheng,Xiao Zhi,Yilin Zhou,Jineng Lv,Yue Zhou,Binrong Wu,Sixiu Liu,Wei Shi,Zongming Song,Jinling Xu,Jia Qu,Dan Xu,Feng Gu
DOI: https://doi.org/10.1038/s41434-022-00352-3
2022-01-01
Gene Therapy
Abstract:X-linked retinitis pigmentosa (XLRP) is the most severe form of Retinitis Pigmentosa (RP) and one of the leading causes of blindness in the world. Currently, there is no effective treatment for RP. In the present study, we recruited a XLRP family and identified a 4 bp deletion mutation (c. 2234_2237del) in RPGR ORF15 with Sanger sequencing, which was located in the exact same region as the missing XES (X chromosome exome sequencing) coverage. Then, we generated cell lines harboring the identified mutation and corrected it via enhanced prime editing system (ePE). Collectively, Sanger sequencing identified a pathogenic mutation in RPGR ORF15 for XLRP which was corrected with ePE. This study provides a valuable insight for genetic counseling of the afflicted family members and prenatal diagnosis, also paves a way for applying prime editing based gene therapy in those patients.
What problem does this paper attempt to address?